Therapeutic Benefit in Rheumatoid Cachexia Illustrated Using a Novel Primary Human Triple Cell Coculture Model
Background. The loss of muscle mass in rheumatoid arthritis (RA), termed rheumatoid cachexia, is predicted to result from the complex interactions between different cell types involved in the maintenance of skeletal muscle mass, namely, myoblasts, fibroblasts, and macrophages. The complexity within...
Saved in:
Main Authors: | Tracey Ollewagen, Gareth S. Tarr, Kathryn H. Myburgh, Helmuth Reuter, Carine Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | International Journal of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2022/1524913 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis
by: Fabiola Gonzalez-Ponce, et al.
Published: (2022-01-01) -
Myokines as Possible Therapeutic Targets in Cancer Cachexia
by: Emilia Manole, et al.
Published: (2018-01-01) -
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
by: Tiantian Wang, et al.
Published: (2025-01-01) -
Citrullinated Autoantigen–Specific T and B Lymphocytes in Rheumatoid Arthritis: Focus on Follicular T Helper Cells and Expansion by Coculture
by: Tim Ammon, et al.
Published: (2025-01-01) -
Resistance Exercise Reduces Skeletal Muscle Cachexia and Improves Muscle Function in Rheumatoid Arthritis
by: Salaheddin Sharif, et al.
Published: (2011-01-01)